Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PEGFILGRASTIM Cause Erythema multiforme? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Erythema multiforme have been filed in association with PEGFILGRASTIM (ZIEXTENZO). This represents 0.0% of all adverse event reports for PEGFILGRASTIM.

13
Reports of Erythema multiforme with PEGFILGRASTIM
0.0%
of all PEGFILGRASTIM reports
0
Deaths
4
Hospitalizations

How Dangerous Is Erythema multiforme From PEGFILGRASTIM?

Of the 13 reports, 4 (30.8%) required hospitalization, and 1 (7.7%) were considered life-threatening.

Is Erythema multiforme Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PEGFILGRASTIM. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does PEGFILGRASTIM Cause?

Device adhesion issue (11,326) Wrong technique in product usage process (10,217) Unintentional medical device removal (8,882) Device malfunction (6,818) Device use error (6,001) Device issue (5,071) Accidental exposure to product (4,967) Device occlusion (3,239) Off label use (3,228) Bone pain (2,266)

What Other Drugs Cause Erythema multiforme?

IBUPROFEN (226) NIVOLUMAB (221) PEMBROLIZUMAB (212) LAMOTRIGINE (210) ACETAMINOPHEN (172) PACLITAXEL (166) AMOXICILLIN (164) ALLOPURINOL (147) CARBOPLATIN (146) CLARITHROMYCIN (131)

Which PEGFILGRASTIM Alternatives Have Lower Erythema multiforme Risk?

PEGFILGRASTIM vs PEGFILGRASTIM-APGF PEGFILGRASTIM vs PEGFILGRASTIM-BMEZ PEGFILGRASTIM vs PEGFILGRASTIM-CBQV PEGFILGRASTIM vs PEGFILGRASTIM-JMDB PEGFILGRASTIM vs PEGINTERFERON ALFA

Related Pages

PEGFILGRASTIM Full Profile All Erythema multiforme Reports All Drugs Causing Erythema multiforme PEGFILGRASTIM Demographics